Dario Cattaneo

8.4k total citations · 1 hit paper
233 papers, 5.8k citations indexed

About

Dario Cattaneo is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Dario Cattaneo has authored 233 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Infectious Diseases, 52 papers in Pediatrics, Perinatology and Child Health and 50 papers in Pharmacology. Recurrent topics in Dario Cattaneo's work include HIV/AIDS drug development and treatment (70 papers), Pharmacological Effects and Toxicity Studies (45 papers) and Antibiotics Pharmacokinetics and Efficacy (41 papers). Dario Cattaneo is often cited by papers focused on HIV/AIDS drug development and treatment (70 papers), Pharmacological Effects and Toxicity Studies (45 papers) and Antibiotics Pharmacokinetics and Efficacy (41 papers). Dario Cattaneo collaborates with scholars based in Italy, United States and Australia. Dario Cattaneo's co-authors include Giuseppe Remuzzi, Norberto Perico, Mohamed H. Sayegh, Sara Baldelli, Emilio Clementi, Cristina Gervasoni, Flavio Gaspari, Eliana Gotti, Valeria Cozzi and Paola Meraviglia and has published in prestigious journals such as The Lancet, Circulation and PLoS ONE.

In The Last Decade

Dario Cattaneo

221 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Delayed graft function in kidney transplantation

2004 781 citations Norberto Perico, Dario Cattaneo et al. profile →

Peers

Countries citing papers authored by Dario Cattaneo

Since Specialization

Citations

This map shows the geographic impact of Dario Cattaneo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dario Cattaneo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dario Cattaneo more than expected).

Fields of papers citing papers by Dario Cattaneo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dario Cattaneo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dario Cattaneo. The network helps show where Dario Cattaneo may publish in the future.

Co-authorship network of co-authors of Dario Cattaneo

This figure shows the co-authorship network connecting the top 25 collaborators of Dario Cattaneo. A scholar is included among the top collaborators of Dario Cattaneo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dario Cattaneo. Dario Cattaneo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Temocillin: A Narrative Review of Its Clinical Reappraisal 2025 ·Antibiotics ·(unknown), Verena Zerbato, (unknown), Alessandra Oliva, Francesco Cogliati Dezza, Nicholas Geremia, Dario Cattaneo, Kristina Nadrah, Mateja Pirš, (unknown), (unknown), Filippo Mearelli, Filippo Giorgio Di Girolamo, (unknown), (unknown), (unknown), Sergio Venturini, Luigi Principe, (unknown), Stefano Di Bella	1
2	Adverse events during intravenous fosfomycin therapy in a real-life scenario. Risk factors and the potential role of therapeutic drug monitoring 2024 ·BMC Infectious Diseases ·Simona Biscarini, Davide Mangioni, (unknown), (unknown), Laura Alagna, Sara Baldelli, Francesco Blasi, Ciro Canetta, Ferruccio Ceriotti, Andrea Gori, Giacomo Grasselli, B Mariani, Antonio Muscatello, Dario Cattaneo, Alessandra Bandera	4
3	Therapeutic Drug Monitoring of Dalbavancin in Real Life: A Two-Year Experience 2023 ·Antibiotics ·Dario Cattaneo, (unknown), Marta Colaneri, (unknown), Camilla Genovese, Riccardo De Giorgi, (unknown), Stefania Merli, Francesco Petri, Andrea Gori	8
4	The case of multiple HIV virological failures in a compliant patient: do pharmacogenetics matter? 2023 ·Journal of Antimicrobial Chemotherapy ·Dario Cattaneo, (unknown), (unknown), (unknown), (unknown), Carlo Federico Perno, Cristina Gervasoni	3
5	Antibiotic Therapy Strategies for Treating Gram-Negative Severe Infections in the Critically Ill: A Narrative Review 2023 ·Antibiotics ·Alberto Corona, Vincenzo De Santis, (unknown), A. Del Prete, Dario Cattaneo, (unknown), Graziella Bonetti, Andrea Patroni, Nicola Latronico	16
6	Physicochemical Characteristics of Antimicrobials and Practical Recommendations for Intravenous Administration: A Systematic Review 2023 ·Antibiotics ·(unknown), (unknown), Antonio Gidaro, (unknown), Dario Cattaneo, Cristina Gervasoni, Maria Calloni, Elena Martini, (unknown), Spinello Antinori, Chiara Cogliati, Andrea Gori, Antonella Foschi	7
7	Therapeutic Drug Monitoring of Anti-TNFα Inhibitors: A Matter of Cut-Off Ranges 2023 ·Pharmaceutics ·Stefania Cheli, (unknown), Francesca Penagini, Gianvincenzo Zuccotti, Giovanna Zuin, Emilio Clementi, Dario Cattaneo	5
8	Role of dalbavancin as combination therapy: evidence from the literature and clinical scenarios 2022 ·Expert Review of Anti-infective Therapy ·Bruno Cacopardo, Dario Cattaneo, Francesco Cortese, Mariagrazia Di Luca, Marco Falcone, Giulia Marchetti, Carlo Tascini, Giusy Tiseo, Mario Venditti	5
9	Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects 2022 ·Cardiovascular Research ·Carla Carnovale, Cristiana Perrotta, Sara Baldelli, Dario Cattaneo, (unknown), Silvia Stella Barbieri, Giulio Pompilio, Chiara Vantaggiato, Emilio Clementi, Marco Pozzi	22
10	Pharmacokinetics and pharmacodynamics of antibiotics in cystic fibrosis: a narrative review 2021 ·International Journal of Antimicrobial Agents ·Elio Castagnola, Giuliana Cangemi, Alessio Mesini, Carlo Castellani, Antonietta Martelli, Dario Cattaneo, Francesca Mattioli	18
11	Paliperidone LAI and Aripiprazole LAI Plasma Level Monitoring in the Prophylaxis of Bipolar Disorder Type I with Manic Predominance 2020 ·Pharmacopsychiatry ·Massimo Carlo Mauri, (unknown), (unknown), (unknown), Chiara Di Pace, Silvia Paletta, Dario Cattaneo	11
12	Dolutegravir-Based Antiretroviral Regimens for HIV Liver Transplant Patients in Real-Life Settings 2020 ·Drugs in R&D ·Dario Cattaneo, Salvatore Sollima, Paola Meraviglia, Laura Milazzo, Davide Minisci, (unknown), Carlo Fìlice, Cristina Gervasoni	4
13	La polipharmacy nel paziente con infezione da HIV: l’esperienza dell’ambulatorio GAP. 2018 ·Cristina Gervasoni, Dario Cattaneo	1
14	Is it time to revise antiretrovirals dosing? A pharmacokinetic viewpoint 2014 ·Journal of the International AIDS Society ·Dario Cattaneo	2
15	Increased Levetiracetam Clearance and Breakthrough Seizure in a Pregnant Patient Successfully Handled by Intensive Therapeutic Drug Monitoring 2014 ·Therapeutic Drug Monitoring ·A. Cappellari, Dario Cattaneo, Emilio Clementi, Alessandra Kustermann	5
16	Tenofovir-induced Renal Tubular Dysfunction in Vertically HIV-infected Patients Associated With Polymorphisms in ABCC2, ABCC4 and ABCC10 Genes 2013 ·The Pediatric Infectious Disease Journal ·Vania Giacomet, Dario Cattaneo, M Viganò, (unknown), (unknown), (unknown), Emilio Clementi, Gianvincenzo Zuccotti	12
17	A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy 2011 ·Pharmacological Research ·Clara Sciorati, Daniela Miglietta, Roberta Buono, Viviana Pisa, Dario Cattaneo, Emanuele Azzoni, Silvia Brunelli, Emilio Clementi	36
18	Optimizing immunosuppressive drug dosing in pediatric renal transplantation 2011 ·Pharmacological Research ·Dario Cattaneo, Alexander A. Vinks	10
19	The Aggravating Mechanisms of Aldosterone on Kidney Fibrosis 2008 ·Journal of the American Society of Nephrology ·Giuseppe Remuzzi, Dario Cattaneo, Norberto Perico	86
20	Effect of combining ACE inhibitor and statin in severe experimental nephropathy 2002 ·Kidney International ·Carla Zoja, Daniela Corna, Daniela Rottoli, Dario Cattaneo, Cristina Zanchi, Susanna Tomasoni, Mauro Abbate, Giuseppe Remuzzi	93

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact